Open AccessIdentification of hub genes in hepatocellular carcinoma using integrated bioinformatic analysis
Author(s) -
Shengni Hua,
Zhonghua Ji,
Yingyao Quan,
Meixiao Zhan,
Hao Wang,
Wei Li,
Yong Li,
Xueling He,
Ligong Lu
Publication year - 2020
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.102969
Subject(s) - gene , hepatocellular carcinoma , downregulation and upregulation , methylation , biology , dna methylation , cancer research , metastasis , promoter , gene expression , cancer , genetics
The molecular mechanisms underlying hepatocellular carcinoma (HCC) progression remain largely undefined. Here, we identified 176 commonly upregulated genes in HCC tissues based on three Gene Expression Omnibus datasets and The Cancer Genome Atlas (TCGA) cohort. We integrated survival and methylation analyses to further obtain 12 upregulated genes for validation. These genes were overexpressed in HCC tissues at the transcription and protein levels, and increased mRNA levels were related to higher tumor grades and cancer stages. The expression of all markers was negatively associated with overall and disease-free survival in HCC patients. Most of these hub genes can promote HCC proliferation and/or metastasis. These 12 hub genes were also overexpressed and had strong prognostic value in many other cancer types. Methylation and gene copy number analyses indicated that the upregulation of these hub genes was probably due to hypomethylation or increased gene copy numbers. Further, the methylation levels of three genes, KPNA2 , MCM3 , and LRRC1 , were associated with HCC clinical features. Moreover, the levels of most hub genes were related to immune cell infiltration in HCC microenvironments. Finally, we identified three upregulated genes ( KPNA2 , TARBP1 , and RNASEH2A ) that could comprehensively and accurately provide diagnostic and prognostic value for HCC patients.